Predicting efficacy and toxicity of drug combinations in salivary gland cancers: A model based on phase II trials
Year: 2026
Type: article
Study design: Systematic Review
Source: Oral Oncology
Institutions: Universitat Autònoma de Barcelona, Royal Marsden NHS Foundation Trust, Institute of Cancer Research, Royal Marsden Hospital, Hospital de Sant Pau, University College London Hospitals NHS Foundation Trust, Humanitas University, IRCCS Humanitas Research Hospital, University of Manchester, The Christie Hospital, The Christie NHS Foundation Trust, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology, Dana-Farber Cancer Institute, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Keywords: salivary gland carcinoma, drug combination prediction, androgen receptor-targeted therapy, androgen deprivation therapy, HER2-targeted therapy, antibody-drug conjugates, cytotoxic chemotherapy, recurrence and metastasis, overall response rate, progression-free survival, overall survival, treatment-related adverse events, additivity model, parametric survival models, clinical trial design
Open Access status: closed
OpenAlex ID: W7232787348
